Financial Results for the quarter ended 30th September 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kerala Ayurveda Limited reported a strong topline for H1 FY26 with total income rising about 27% year-on-year to Rs 7,462.37 lakhs from Rs 5,874.60 lakhs in H1 FY25. However, the company swung from a profit of Rs 410.81 lakhs in H1 FY25 to a loss of Rs (433.18) lakhs in H1 FY26 on a consolidated basis, as total expenses of Rs 7,863.55 lakhs outpaced revenue growth. For the standalone quarter ended September 2025, revenue rose to Rs 3,654.06 lakhs but the company posted a loss after tax of Rs (635.94) lakhs compared to a profit of Rs 364.81 lakhs in the same quarter last year. Cost of materials, employee expenses and other overheads all expanded sharply, eroding margins. The statutory auditor G Joseph & Associates issued an unmodified (clean) limited review opinion on the results.
Despite healthy revenue growth, the sharp swing to losses and negative operating cash flow of Rs (1,620.95) lakhs on a consolidated basis are negative signals for shareholders and could pressure the stock in the near term. Investors should watch for margin recovery in upcoming quarters.